IES Holdings, Inc.

IESC

CIK 0001048268 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$871M
↑+16.2% +$121Mvs FY2024 (Q4)
Operating Income
$98M
↑+31.0% +$23Mvs FY2024 (Q4)
Net Income
$92M
↑+59.1% +$34Mvs FY2024 (Q4)
Gross Profit
$220M
↑+23.6% +$42Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
83/100
  • Profitability
    100ROIC 38.7% (10% = solid, 20%+ = moat)
  • Liquidity
    61Current Ratio 1.71 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 2.37x (1.0+ = capital-efficient)
  • Growth
    71Revenue YoY +16.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    67Op Margin 11.2% · trend +1.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project IESC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$186.53
Total enterprise IV
$3.76B
Diluted shares
0.02B
Terminal PV
$2.73B (72% of total)
Year-5 FCF
$322M
YearProjected FCFDiscounted PV
+1$236M$215M
+2$255M$211M
+3$276M$207M
+4$298M$203M
+5$322M$200M
Terminal$4.39B$2.73B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$101M
investment in PP&E
Stock buybacks (TTM)
$44M
share count reduction
Stock-based comp (TTM)
$15M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.66B
everything owned
Total liabilities
$693M
everything owed
Stockholders' equity
$961M
shareholder claim
Net debt
$-89M
Net cash position ($89M)

Recent performance · 63 quarters

Revenue↑+16.2% +$121M
$871M
Net Income↑+59.1% +$34M
$92M
Free Cash Flow↓-178.3% -$43M
$-19M
Operating Margin↑+1.3pts
11.2%

Drill down